• Slideshow
  • Slideshow
 
GROUP LEADER

DR. MICHAEL POTENTE

hide CV

Download CV

GENERAL INFORMATION
CURRENT POSITION: Group leader and consultant cardiologist
WORK ADDRESS: Max Planck Institute for Heart and Lung ResearchAngiogenesis & Metabolism LaboratoryLudwigstr. 43
D-61231, Bad Nauheim, Germany
Tel. +49 6032 705 1107 – Fax +49 6032 705 1104E-mail: michael.potente@mpi-bn.mpg.de
ACADEMIC EDUCATION
10/1996 – 12/2002 Studies of Medicine, Goethe-University Frankfurt, and University of Toronto, Toronto, ON, Canada
09/1998 – 04/2003 Experimental doctoral thesis (MD student), Goethe-University, Frankfurt
SCIENTIFIC DEGREES
MD THESIS: Department of Cardiovascular Physiology, Goethe-University Frankfurt,04/2003, Prof. Dr. R. Busse (summa cum laude)
BOARD CERTIFICATION: Internal Medicine (2011) and Cardiology (2011), Department ofInternal Medicine III, Cardiology, Goethe-University Frankfurt
HABILITATION: Department of Internal Medicine III, Cardiology, Goethe-University Frankfurt,06/2013, Prof. Dr. A.M. Zeiher
Professional career
01/2003 – 06/2004 Intern, Department of Internal Medicine III (Prof. Dr. A.M. Zeiher), Cardiology, Goethe-University, Frankfurt
05/2003 – 07/2007 Postdoctoral training, Institute for Cardiovasular Regeneration (Prof. Dr. S. Dimmeler), Centre for Molecular Medicine, Goethe-University, Frankfurt
07/2004 – 09/2011 Resident, Department of Internal Medicine III, Cardiology (Prof. Dr. A.M. Zeiher), Goethe-University, Frankfurt
10/2011 – 11/2012 Senior physician, Department of Internal Medicine III, Cardiology, Goethe-University, Frankfurt
12/2012 – present Max Planck Research Group Leader, Max Planck Institute for Heart and Lung Research, Bad Nauheim
01/2013 – present Consultant cardiologist, Department of Internal Medicine III, Cardiology, Goethe-University, Frankfurt
Awards & honours
2003 Young Investigator Award, Goethe-University, Faculty of Medicine
2004 Best Thesis Award, Goethe-University, Faculty of Medicine
2006 Award of the Dr. Walter and Luise Freundlich Foundation
2007 Melvin L. Marcus Young Investigator Award in Basic Cardiovascular Sciences finalist, American Heart Association
2009 Louis N. and Arnold M. Katz Basic Science Research Prize, American Heart Association
2009 Award of the Herbert and Hedwig Eckelmann Foundation
2011 Principle investigator, Excellence Cluster Cardiopulmonary System
2011 Principal Investigator, German Centre for Cardiovascular Research
2012 Adjunct Investigator, Cluster of Excellence Frankfurt Macromolecular Complexes
2012 Albert Fraenkel Prize of the German Cardiac Society
2012 Editorial board member Circulation Research
2012 Award of the Dr. Paul und Cilli Weill-Foundation
2012 European Research Council Starting Grant
2012 Award of the Theodor Stern Foundation
2014 EMBO Young Investigator Programme
Research funding
2004 – 2005 Goethe-University, Faculty of Medicine, Young Investigator Grant
2007 – 2009 Deutsche Forschungsgemeinschaft, Individual Research Grant
2010 – 2013 Deutsche Forschungsgemeinschaft, SFB834
2011 – 2015 German Centre for Cardiovascular Research
2012 – 2013 Cluster of Excellence Frankfurt Macromolecular Complexes
2012 – 2013 Leducq Transatlantic Network of Excellence (ARTEMIS)
2012 – 2017 Max Planck Society, Max Planck Research Group
2012 – 2017 European Research Council Starting Grant (ANGIOMET)
2012 – 2017 BELSPO, IAP Phase VII (ICePath)
2014 – 2016 LOEWE Research Cluster (Ub-Net)
2014 – 2017 Deutsche Forschungsgemeinschaft, SFB834
2015 – 2017 EMBO Young Investigator
Citation metrics (ISI Web of Knowledge)
Publications: 27  – total citations: 3783 – average citations per item: 140.1 – h-index: 19
Editorial activities
2012 – present Circulation Research
Solicited reviewer for journals
Science, Nature, Nature Medicine, Nature Reviews Molecular Cell Biology, Nature Protocols, Nature Communications, Developmental Cell, Cell Reports, Journal of Clinical Investigation, Circulation, Circulation Research, EMBO Journal, EMBO Molecular Medicine, Blood
Solicited reviewer for grants
European Reseach Council (ERC), European Molecular Biology Organisation (EMBO,) Deutsche Forschungsgemeinschaft (DFG), The Netherlands Organisation for Scientific Research (NWO), The National Fund for Scientific Research (FWO, Belgium), Deutsche Krebshilfe

 

People

 

The Institute

The Max Planck Institute for Heart and Lung Research and its predecessor have a long and rich scientific history in cardiovascular biology and medicine. For several decades, the institute was home of the German Cardiology Society and helped to lay the foundations of modern research-orientated cardiology in Germany. Moreover, the former clinical department of the institute, the Kerckhoff Hospital, became one of Germany’s leading heart centres.

 

Today’s MPI for Heart and Lung Research emerged in 2005 from the former MPI for Physiological and Clinical Research. It is located in two research buildings, one of which opened in 2009. The institute has four departments devoted to cardiovascular and pulmonary research, which are headed by Thomas Braun (Cardiac Development and Remodelling), Stefan Offermanns (Pharmacology), Didier Stainier (Developmental Genetics) and Werner Seeger (Lung Development and Remodelling). The scientific expertise of the institute is strengthened by five independent junior research groups, which are supported by highly competitive research funding from the European Research Council, the Max Planck Society, the Deutsche Forschungsgemeinschaft, the Excellence Cluster Cardio-Pulmonary System (ECCPS) and the Hessian excellence initiative. Research in the institute is assisted by strong scientific support groups and includes state-of-the-art transgenic- (mouse and zebrafish), imaging-, proteomics-, next generating sequencing- and bioinformatic services.

 

The institute runs the International Max Planck Research School for Heart and Lung Research (IMPRS-HLR), which enables the identification and training of highly talented PhD students from all over the world. The IMPRS-HLR is well integrated and collaborates with graduate schools and doctoral programs at the Universities of Frankfurt and Giessen.

 

The Max Planck Institute for Heart and Lung Research is also part of major research alliances focusing on various aspects of cardiovascular and lung disease. These include several DFG-funded Collaborative Research Centres (together with the Universities of Frankfurt, Giessen, Heidelberg, Mainz and Marburg) as well as the DFG / BMBF-sponsored Excellence Cluster Cardiopulmonary System (ECCPS). Furthermore, the institute plays a pivotal role in several state-sponsored LOEWE initiatives, i.e. the LOEWE centres for Cell and Gene Therapy (CGT) or the LOEWE research cluster Ubiquitin networks (Ub-Net). The MPI is also an integral part of the prestigious German Centres for Cardiovascular Research (DZHK) and the German Centre for Lung Research (DZL).

 

 

ANGIOGENESIS & METABOLISM LABORATORY
ANGIOGENESIS & METABOLISM LABORATORY
ANGIOGENESIS & METABOLISM LABORATORY
ANGIOGENESIS & METABOLISM LABORATORY